To compare the efficacy of entecavir and lamivudine in preventing HBV reactivation in patients seropositive for the hepatitis B surface antigen with untreated diffuse large B-cell lymphoma receiving chemotherapy treatment with rituximab , cyclophosphamide , doxorubicin , vincristine , and prednisone ( R-CHOP ) .